Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-13-054829

Options or other derivatives

  • Chief Executive Officer acquired 435,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Carpenter George C IV Chief Executive Officer 2013-10-08 Grant or award · Option to Purchase +435,000 435,000 D
Loading xslF345X03/v357190_form4.xml…